Manitowoc (NYSE:MTW – Get Free Report) is one of 436 publicly-traded companies in the “Machinery” industry, but how does it contrast to its peers? We will compare Manitowoc to related businesses based on the strength of its earnings, dividends, risk, analyst recommendations, institutional ownership, profitability and valuation. Analyst Ratings This is a summary of current […]

Kemper (NYSE:KMPR – Get Free Report) is one of 311 public companies in the “Insurance” industry, but how does it contrast to its competitors? We will compare Kemper to related companies based on the strength of its risk, profitability, analyst recommendations, earnings, valuation, institutional ownership and dividends. Analyst Recommendations This is a breakdown of current […]

nCino (NASDAQ:NCNO – Get Free Report) is one of 953 public companies in the “Software” industry, but how does it compare to its rivals? We will compare nCino to related companies based on the strength of its profitability, analyst recommendations, institutional ownership, valuation, risk, dividends and earnings. Earnings and Valuation This table compares nCino and […]

Trex (NYSE:TREX – Get Free Report) is one of 93 public companies in the “Building Products” industry, but how does it compare to its competitors? We will compare Trex to related businesses based on the strength of its analyst recommendations, earnings, valuation, profitability, institutional ownership, risk and dividends. Volatility and Risk Trex has a beta […]

Lamar Advertising (NASDAQ:LAMR – Get Free Report) is one of 35 publicly-traded companies in the “Specialized REITs” industry, but how does it weigh in compared to its competitors? We will compare Lamar Advertising to similar businesses based on the strength of its profitability, dividends, institutional ownership, risk, valuation, analyst recommendations and earnings. Profitability This table […]

Amarin (NASDAQ:AMRN – Get Free Report) is one of 897 publicly-traded companies in the “Pharmaceuticals” industry, but how does it compare to its competitors? We will compare Amarin to related businesses based on the strength of its dividends, earnings, risk, analyst recommendations, valuation, institutional ownership and profitability. Risk & Volatility Amarin has a beta of […]

Theravance Biopharma (NASDAQ:TBPH – Get Free Report) is one of 897 publicly-traded companies in the “Pharmaceuticals” industry, but how does it compare to its competitors? We will compare Theravance Biopharma to related businesses based on the strength of its dividends, earnings, risk, analyst recommendations, valuation, institutional ownership and profitability. Risk & Volatility Theravance Biopharma has […]